6609.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:52):

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide...

Stats
Dzisiejszy wolumen	500.00
Średni wolumen	65 259.00
Kapitalizacja rynkowa	669.00M
EPS	HKD0 ( 2024-03-28 )
Następna data zysków	( HKD0 ) 2024-05-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-6.58
ATR14	HKD0.158 (0.88%)

Wolumen Korelacja

Długi: -0.17 (neutral)

Krótki: 0.25 (neutral)

Signal:(37.393) Neutral

Shanghai HeartCare Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shanghai HeartCare Korelacja - Waluta/Towar

0.76
( moderate )

0.82
( strong )

0.55
( weak )

0.69
( moderate )

-0.83
( strong negative )

-0.28
( neutral )

Shanghai HeartCare Finanse

Annual	2023
Przychody:	HKD232.34M
Zysk brutto:	HKD163.76M (70.48 %)
EPS:	HKD-2.47

FY	2023
Przychody:	HKD232.34M
Zysk brutto:	HKD163.76M (70.48 %)
EPS:	HKD-2.47

FY	2022
Przychody:	HKD183.03M
Zysk brutto:	HKD124.33M (67.93 %)
EPS:	HKD-5.24

FY	2021
Przychody:	HKD90.09M
Zysk brutto:	HKD54.95M (61.00 %)
EPS:	HKD-6.18

Financial Reports:

No articles found.

Shanghai HeartCare

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.